We are live on ! Find out more
AF

AtlasMark Financial Portfolio holdings

AUM $155M
1-Year Est. Return 17.25%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$43.6M
AUM Growth
+$3.49M
Cap. Flow
-$25.9K
Cap. Flow %
-0.06%
Top 10 Hldgs %
68.57%
Holding
35
New
1
Increased
5
Reduced
6
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 5.98%
2 Communication Services 1.97%
3 Consumer Discretionary 1.64%
4 Healthcare 0.67%
5 Financials 0.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBUX icon
26
Starbucks
SBUX
$120B
$422K 0.97%
4,800
VZ icon
27
Verizon
VZ
$195B
$412K 0.94%
6,710
IMCG icon
28
iShares Morningstar Mid-Cap Growth ETF
IMCG
$3.92B
$394K 0.9%
9,000
HD icon
29
Home Depot
HD
$331B
$295K 0.68%
1,350
UNH icon
30
UnitedHealth
UNH
$376B
$294K 0.67%
1,000
BRK.B icon
31
Berkshire Hathaway Class B
BRK.B
$1.1T
$289K 0.66%
1,275
QCOM icon
32
Qualcomm
QCOM
$155B
$282K 0.65%
3,200
ADBE icon
33
Adobe
ADBE
$99.5B
$264K 0.61%
800
FHLC icon
34
Fidelity MSCI Health Care Index ETF
FHLC
$3.28B
$219K 0.5%
+4,400
New +$204K
BIIB icon
35
Biogen
BIIB
$30B
-1,222
Closed -$285K

Similar funds

AtlasMark Financial's Q4 2019 Portfolio in Review

As of Q4 2019, AtlasMark Financial held 35 positions worth $43.6M, up 8.7% from $40.1M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

AtlasMark Financial's Q4 2019 filing shows 1 new, 5 increased, 6 reduced and 1 closed positions. Its largest new stake was Fidelity MSCI Health Care Index ETF: 4,400 shares worth $219K. The largest sale was Biogen, an estimated $285K.

By sector, the portfolio is most concentrated in Technology at 6% of assets, up from 5.5% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • AtlasMark Financial's largest Q4 2019 buy was Fidelity MSCI Health Care Index ETF: 4,400 shares worth $219K.
  • AtlasMark Financial added most to iShares Core S&P Small-Cap ETF in Q4 2019, an estimated $85.2K increase.
  • AtlasMark Financial's biggest Q4 2019 reduction was iShares S&P 500 Value ETF, cutting an estimated $43.3K.
  • AtlasMark Financial fully exited Biogen in Q4 2019, selling an estimated $285K.
  • AtlasMark Financial's ten largest holdings make up 69% of its $43.6M portfolio in Q4 2019.
  • AtlasMark Financial opened 1 new position and closed 1 in Q4 2019.
  • AtlasMark Financial's portfolio value rose 8.7% quarter-over-quarter to $43.6M.

Based on AtlasMark Financial's 13F filing for Q4 2019, filed 22 Apr 2026.